The costs associated with sleep symptoms among patients with fibromyalgia

Author： Wagner Jan-Samuel   Chandran Arthi   DiBonaventura Marco   Cappelleri Joseph C  

Publisher： Informa Healthcare

ISSN： 1473-7167

Source： Expert Review of Pharmacoeconomics and Outcomes Research, Vol.13, Iss.1, 2013-02, pp. : 131-139

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of fibromyalgia and its symptoms

By Staud Roland  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 11, 2007-08 ,pp. : 1629-1642

Informa Healthcare

Access to resources Recommend Favorite

Treatment Interruptions and Non-Adherence with Imatinib and Associated Healthcare Costs: A Retrospective Analysis among Managed Care Patients with Chronic Myelogenous Leukaemia

By Darkow Theodore  

PharmacoEconomics, Vol. 25, Iss. 6, 2007-01 ,pp. : 481-496

Adis International

Access to resources Recommend Favorite

Fibromyalgia exacts substantial costs in Canada

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 461, 2004-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

The Italian version of the Fibromyalgia Impact Questionnaire (FIQ) is a "reliable and valid" tool for measuring functional disability among Italian-speaking patients with fibromyalgia

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 427, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Duloxetine: In Patients with Fibromyalgia

By Curran Monique P.  

Drugs, Vol. 69, Iss. 9, 2009-06 ,pp. : 1217-1227

Adis International

Access to resources Recommend Favorite